CAC: Apparatus, Autotransfusion
What it covers
An autotransfusion apparatus is a device used to collect and reinfuse the blood lost by a patient due to surgery or trauma.
The identification in 21 CFR 868.5830, autotransfusion apparatus. FDA gives CAC no definition of its own, so the regulation’s describes it.
FDA flags CAC devices as life-sustaining or life-supporting.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K241236 | XTRA Collection sets; XTRA Sequestration set X | Sorin Group Italia S.R.L. | Aug 16, 2024 | Special |
| K240426 | Aventus Clot Management System | Inquis Medical | May 14, 2024 | Traditional |
| K240584 | XTRA Autotransfusion System (with XTRA Bowl sets) | Sorin Group Italia S.R.L. | Apr 29, 2024 | Special |
| K231782 | FlowSaver Blood Return System (80-101) | Inari Medical, Inc. | Jul 14, 2023 | Special |
| K221483 | FlowSaver Blood Return System | Inari Medical, Inc. | Feb 17, 2023 | Traditional |
| K221722 | Haemonetics Cell Saver Elite/Elite+ Autotransfusion System (CSE-E-US/CSE-EW-US) | Haemonetics Corporation | Nov 15, 2022 | Traditional |
| K201305 | Auto transfusion (ATS) Chest Drains: Ocean Water Seal Chest Drain, Oasis Dry Suction Water Seal Chest Drain, Express Dry Seal Chest Drain | Atrium Medical Corporation | Sep 3, 2021 | Traditional |
| K210862 | Hemafuse System | Sisu Global Health | Jul 29, 2021 | Traditional |
| K210176 | FlowSaver Blood Filter | Inari Medical | Jul 22, 2021 | Traditional |
| K210089 | CATSmart, Automated Blood Processing Autotransfusion System | Fresenius Kabi AG | Feb 11, 2021 | Special |
Clearances by year
26 CAC 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2024 | 3 | 91 |
| 2023 | 2 | 149 |
| 2022 | 1 | 154 |
| 2021 | 4 | 155 |
| 2020 | 1 | 180 |
| 2019 | 1 | 28 |
| 2018 | 2 | 143 |
| 2017 | 1 | 126 |
| 2016 | 2 | 151 |
| 2014 | 3 | 269 |
| 2013 | 1 | 35 |
| 2012 | 3 | 90 |
| 2011 | 2 | 25 |
Who submits
14 applicants cleared a CAC device since 2011. 73% of the clearances went to applicants in United States, then Germany (15%), Italy (8%) and Canada (4%). By type: Traditional 69% and Special 31%.
| Applicant | Clearances since 2011 |
|---|---|
| Fresenius Kabi AG | 4 |
| Sorin Group Italia S.R.L. | 4 |
| Haemonetics Corporation | 3 |
| Teleflexmedical, Inc. | 3 |
| Haemonetics Corp. | 2 |
| Inari Medical, Inc. | 2 |
| Atrium Medical Corporation | 1 |
| Inari Medical | 1 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 868.5830.
Standards
21 CFR 868.5830 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent CAC clearances declared.
Ask about CAC
Questions about CAC
What is FDA product code CAC?
Product code CAC, “Apparatus, Autotransfusion” in FDA's classification database, is a Class II device type under 21 CFR 868.5830 (autotransfusion apparatus), reviewed by FDA's Anesthesiology panel. FDA's 510(k) database lists 195 clearances under CAC, 26 of them since 2011.
How many 510(k) clearances are there under CAC?
FDA’s 510(k) database listed 195 clearances under CAC as of Oct 29, 2026, 26 of them decided since 2011; the most recent decision was Aug 16, 2024. The Predicate Finder searches the live database.
Which companies have the most CAC clearances?
Since 2011: Fresenius Kabi AG (4), Sorin Group Italia S.R.L. (4), Haemonetics Corporation (3), Teleflexmedical, Inc. (3) and Haemonetics Corp. (2). 14 applicants have cleared a CAC device in that time.